Ischemic heart disease decisions — 2025

The Board denied the Veteran's claims for earlier effective dates for service connection for PTSD, coronary artery disease, and hypertension.

The February 2016 rating decision that denied service connection for a heart disability is not final, and therefore cannot be revised or reversed based on clear and unmistakable evidence (CUE).

The Board remands the claim for a heart condition, to include congestive heart failure, due to an inadequate VA examination and opinion regarding service connection based on in-service toxic exposure.

The Veteran is granted special monthly compensation (SMC) at the R-1 rate due to his service-connected heart and PTSD disabilities, separately.

The Board denied service connection for a heart condition, diagnosed as CAD, and remanded the claim for hypertension.

The Board denied an initial disability rating in excess of 60 percent for the Veteran's hypertensive heart disease, as the evidence did not show that his symptoms warranted a higher rating.

The Board remands the claims for service connection for aortic valve stenosis, arteriosclerotic heart disease (claimed as heart disease), and hypertension due to insufficient development of evidence regarding potential herbicide exposure during service.

The Board denied a disability rating in excess of 70 percent for PTSD and granted service connection for heart, OSA, and GERD disabilities that are secondary to the Veteran's service-connected PTSD.

The Board denied service connection for hypertensive heart disease, erectile dysfunction, right and left lower extremity neuropathy, and bilateral hearing loss as there was no evidence of in-service exposure to herbicides or a nexus between the claimed disorders and service.

The Board remands the claims for an initial disability rating in excess of 30 percent for insomnia disorder and associated anxiety, as well as a total disability rating based on individual unemployability (TDIU), due to pre-decisional failure of the duty to assist.

The Board remands the claims for service connection for coronary artery disease, peripheral vascular disease, and chronic kidney disease to schedule VA examinations that consider medical treatise evidence regarding toxic exposures at Camp Lejeune.

The Board denied service connection for a heart disorder, right knee disorder, osteoporosis, pituitary brain tumor, and skin cancer as the evidence did not show that these conditions were causally or etiologically related to any disease, injury, or incident in service.

The Board remands the claim for an increased rating for heart disease to obtain additional medical records.

The Board granted service connection for type II diabetes mellitus, coronary artery disease with angina, myocardial infarction, and peripheral neuropathy of the bilateral lower and upper extremities due to exposure to herbicide agents during service. The claims for deep vein thrombosis and cellulitis were remanded.

The Board denied service connection for ischemic heart disease as new and relevant evidence was not presented or secured.

The Board denied service connection for hearing loss and tinnitus, while remanding the claims for coronary artery disease (CAD), prostate cancer, obstructive sleep apnea, cataracts, and thyroid removal due to a duty to assist error.

The Board granted service connection for coronary artery disease, hypertension, and prostate cancer based on the Veteran's exposure to herbicide agents during his service near the Korean Demilitarized Zone.

The Board remands the claim for service connection for heart disorder, to include ischemic heart disease, for further development and examination.

The Board denied the increased rating claim for coronary artery disease and TDIU from July 30, 2019, to October 16, 2019.

The Board granted service connection for type II diabetes mellitus, coronary artery disease with angina, myocardial infarction, and peripheral neuropathy of the bilateral lower and upper extremities due to exposure to herbicide agents during service. The claims for deep vein thrombosis and cellulitis were remanded.